SAN DIEGO, Oct. 22, 2015 /PRNewswire/ -- Neurocrine
Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company
will report its third quarter 2015 financial results after the
Nasdaq market closes on Thursday, October
29, 2015. Neurocrine will then host a live conference
call and webcast to discuss its financial results and provide a
Company update Thursday afternoon, October
29, 2015 at 5:00 p.m. Eastern
Time (2:00 p.m. Pacific
Time).
Participants can access the live conference call by dialing
866-952-1907 (US) or 785-424-1826 (International) using the
conference ID: NBIX. The call can also be accessed via the webcast
through the Company's website at http://www.neurocrine.com.
If you are unable to attend the webcast and would like further
information on this announcement please contact the Investor
Relations Department at Neurocrine Biosciences at (858) 617-7600.
A replay of the conference call will be available
approximately one hour after the conclusion of the call by dialing
800-839-5127 (US) or 402-220-2692 (International) using the
conference ID: NBIX. The call will be archived for one month.
Neurocrine Biosciences, Inc. discovers and develops innovative
and life-changing pharmaceuticals, in diseases with high unmet
medical needs, through its novel R&D platform, focused on
neurological and endocrine based diseases and disorders. The
Company's two lead late-stage clinical programs are elagolix, a
gonadotropin-releasing hormone antagonist for women's health that
is partnered with AbbVie Inc., and NBI-98854, a vesicular monoamine
transporter 2 inhibitor for the treatment of movement disorders.
Neurocrine intends to maintain certain commercial rights to its
VMAT2 inhibitor for evolution into a fully-integrated
pharmaceutical company.
Neurocrine Biosciences, Inc. news releases are available through
the Company's website via the internet at
http://www.neurocrine.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-conference-call-and-webcast-to-report-third-quarter-2015-results-300163274.html
SOURCE Neurocrine Biosciences, Inc.